[go: up one dir, main page]

DK437289D0 - Prodrug derivatives of thyrotropin-releasing hormone (trh) - Google Patents

Prodrug derivatives of thyrotropin-releasing hormone (trh)

Info

Publication number
DK437289D0
DK437289D0 DK437289A DK437289A DK437289D0 DK 437289 D0 DK437289 D0 DK 437289D0 DK 437289 A DK437289 A DK 437289A DK 437289 A DK437289 A DK 437289A DK 437289 D0 DK437289 D0 DK 437289D0
Authority
DK
Denmark
Prior art keywords
trh
thyrotropin
releasing hormone
product derivatives
derivatives
Prior art date
Application number
DK437289A
Other languages
Danish (da)
English (en)
Inventor
Hans Bundgaard
Judi Moess
Original Assignee
Hans Bundgaard
Judi Moess
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Bundgaard, Judi Moess filed Critical Hans Bundgaard
Priority to DK437289A priority Critical patent/DK437289D0/da
Publication of DK437289D0 publication Critical patent/DK437289D0/da
Priority to JP2512601A priority patent/JPH05500061A/ja
Priority to CA002066449A priority patent/CA2066449A1/en
Priority to US07/842,181 priority patent/US5405834A/en
Priority to EP90913468A priority patent/EP0490947A1/en
Priority to PCT/DK1990/000228 priority patent/WO1991003487A1/en
Priority to KR1019920700492A priority patent/KR920703628A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Metal Rolling (AREA)
  • Control Of Metal Rolling (AREA)
  • Peptides Or Proteins (AREA)
DK437289A 1989-09-04 1989-09-04 Prodrug derivatives of thyrotropin-releasing hormone (trh) DK437289D0 (da)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DK437289A DK437289D0 (da) 1989-09-04 1989-09-04 Prodrug derivatives of thyrotropin-releasing hormone (trh)
JP2512601A JPH05500061A (ja) 1989-09-04 1990-09-03 甲状腺刺激ホルモン放出ホルモンのプロドラッグ誘導体
CA002066449A CA2066449A1 (en) 1989-09-04 1990-09-03 Prodrug derivatives of thyrotropin-releasing hormone (trh)
US07/842,181 US5405834A (en) 1989-09-04 1990-09-03 Prodrug derivatives of thyrotropin-releasing hormone (TRH)
EP90913468A EP0490947A1 (en) 1989-09-04 1990-09-03 Prodrug derivatives of thyrotropin-releasing hormone (trh)
PCT/DK1990/000228 WO1991003487A1 (en) 1989-09-04 1990-09-03 Prodrug derivatives of thyrotropin-releasing hormone (trh)
KR1019920700492A KR920703628A (ko) 1989-09-04 1990-09-03 티로트로핀-방출 호르몬(trh)의 프로드러그 유도체

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK437289A DK437289D0 (da) 1989-09-04 1989-09-04 Prodrug derivatives of thyrotropin-releasing hormone (trh)

Publications (1)

Publication Number Publication Date
DK437289D0 true DK437289D0 (da) 1989-09-04

Family

ID=8132949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK437289A DK437289D0 (da) 1989-09-04 1989-09-04 Prodrug derivatives of thyrotropin-releasing hormone (trh)

Country Status (7)

Country Link
US (1) US5405834A (ja)
EP (1) EP0490947A1 (ja)
JP (1) JPH05500061A (ja)
KR (1) KR920703628A (ja)
CA (1) CA2066449A1 (ja)
DK (1) DK437289D0 (ja)
WO (1) WO1991003487A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543390A (en) * 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
US5827819A (en) * 1990-11-01 1998-10-27 Oregon Health Sciences University Covalent polar lipid conjugates with neurologically active compounds for targeting
US7045543B2 (en) 2001-11-05 2006-05-16 Enzrel Inc. Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
WO2003089459A2 (en) * 2002-04-19 2003-10-30 University Of Florida Thyrotropin-releasing hormone analogues and their therapeutic applications
AU2003285200A1 (en) * 2002-11-09 2004-06-03 Nobex Corporation Modified carbamate-containing prodrugs and methods of synthesizing same
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
BRPI0517790A (pt) * 2004-11-12 2008-10-21 Neurochem Int Ltd métodos e composições fluoradas para tratar doenças relacionadas à amilóide
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学(国际)有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
BRPI0519243A2 (pt) 2004-12-22 2009-01-06 Neurochem Int Ltd mÉtodos e composiÇÕes para tratar doenÇas relacionadas a amilàide
WO2006096829A2 (en) * 2005-03-09 2006-09-14 Roger Williams Hospital Thyrotropin-releasing hormone analogs and method of use
US20070232556A1 (en) * 2006-03-31 2007-10-04 Montine Thomas J Methods and compositions for the treatment of neurological diseases and disorders
WO2008019394A2 (en) * 2006-08-11 2008-02-14 The Government Of The United States Of America As Represented By The Secretary, Dept Of Health And Human Services Methods for treatment and diagnosis of psychiatric disorders
KR101742179B1 (ko) 2006-10-12 2017-05-31 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
EP2342356A4 (en) 2008-09-29 2012-11-21 Univ Ben Gurion AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF
WO2018226992A1 (en) 2017-06-07 2018-12-13 Adrx, Inc. Tau aggregation inhibitors
EP3668886A2 (en) 2017-08-18 2020-06-24 Adrx, Inc. Tau aggregation peptide inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
CA1256650A (en) * 1983-03-25 1989-06-27 Toshinari Tamura Process of producing 2-azetidinone-4-substituted compounds, and medicaments containing the compounds

Also Published As

Publication number Publication date
WO1991003487A1 (en) 1991-03-21
EP0490947A1 (en) 1992-06-24
KR920703628A (ko) 1992-12-18
JPH05500061A (ja) 1993-01-14
US5405834A (en) 1995-04-11
CA2066449A1 (en) 1991-03-05

Similar Documents

Publication Publication Date Title
DK437289D0 (da) Prodrug derivatives of thyrotropin-releasing hormone (trh)
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
DK22588D0 (da) Peptidderivater
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
ATE190066T1 (de) Neuartige peptidderivate
DK612689D0 (da) Peptidderivater
FI960584L (fi) Terapeuttisia peptidijohdannaisia
DK163689A (da) Peptidderivater
FI923527L (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-piperidino-4-hydroksikromaanijohdannaisten valmistamiseksi
FI925871L (fi) Menetelmä terapeuttisesti aktiivisten fenyyliguanidiinijohdannaisten valmistamiseksi
DK375789A (da) Peptidderivater
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI943638L (fi) Bombesiinin fenyylialaniinianalogeja
FI94351B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
NO174463C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidinderivater
DK4390A (da) Peptidderivater
DK177789D0 (da) Peptidderivater
FI893434A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten sykloalkyylitiatsolijohdannaisten valmistamiseksi
DK657189A (da) Peptidderivater
DK679488D0 (da) Peptidderivater
FI912733L (fi) Menetelmä terapeuttisesti käyttökelpoisten /(1-aryylipyrrolidin-2-yyli)metyyli/piperatsiinijohdannaisten valmistamiseksi
DK171489D0 (da) Peptidderivater
FI942927A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten tetrahydronaftaleenijohdannaisten valmistamiseksi
GB8800143D0 (en) Manufacture of right angle brackets &c